Immune Network Research Limited Company Profile

20:18 EDT 19th September 2018 | BioPortfolio

Profile:A Vancouver, BC - based company, Immune Network Research Ltd. identifies outstanding commercial opportunities for new drug treatments, and takes them closer to market through rapid completion of critical milestones. Completion of these milestones is followed by licensing, alliances or spin-offs in order to create maximum return on investment for our shareholders.


Immune Network Research Ltd. has established a multi-disciplinary network of world class pharmacology experts in order to carefully select candidate drugs and technology.

Each prospective candidate opportunity will have an underlying foundation of strong science, protectable intellectual property, and a clearly identifiable commercial niche.

With rapid return on investment as the underlying basis of the strategy, the acquisition of rights, the addition of value, and the rapid divestiture through licenses, alliances or spin-offs will create a wide technology portfolio targeting important diseases, including Alzheimer's disease, Asthma, and AIDS.

Immune Network Research Ltd. will differentiate itself from other biotech companies by earning a strong reputation for successful commercialization of drugs aimed at these and other mainstream diseases.

Technological and Scientific Network:

Our extensive Network of Experts communicate and exchange information using the latest advanced business tools. The core group of the Company's Network includes pharmacology experts Drs. Brian Conway, Michael Grant, Sultan Karim, Heinz Köhler, Clive Page, and Michael Walker. Each of these experts provides a fundamental contribution to the Network.

Current Portfolio:

Our strategy allows for continuous project portfolio expansion and diversification. We believe this reduces risk for shareholders. Currently, we are developing products in three therapeutic areas:

Alzheimer's Disease: Immune Network Research Ltd. has acquired rights to a patent for the use of a group of compounds, based on an existing drug approved for another disease, in the treatment of Alzheimer's disease. The company anticipates that the next milestone for this project will be Phase II clinical trials.

Asthma: Immune Network Research Ltd., along with its joint venture partner Bridge Pharma, is carrying out research on a group of novel, non-steroidal, disease modifying agents for the treatment of asthma. The next milestone for this project will be the completion of laboratory studies on this group of compounds and selection of a clinical candidate

AIDS: Immune Network Research Ltd. has recently reacquired a 100% in this project involving a monoclonal antibody (1F7) which may represent a unique advancement in the treatment of AIDS. The company's former joint venture partner, ImmPheron, has completed pre-clinical research on the 1F7 antibody. This novel approach for treating HIV infection is aimed at resetting the body's immune system to continue to fight the AIDS virus even as it mutates. Immune Network is currently preparing a regulatory package for clinical trial approval.


3650 Wesbrook Mall
British Columbia
V6S 2L2


Phone: 604 222 5541
Fax: 604 222 5542

News Articles [1314 Associated News Articles listed on BioPortfolio]

Insulin gives an extra boost to the immune system

(University Health Network) The role of insulin as a boost to the immune system to improve its ability to fight infection has been detailed for the first time by Toronto General Hospital Research Inst...

Carilion Clinic Joins TriNetX Network to Expand Clinical Research and Collaboration Opportunities

TriNetX, the global health research network, will announce the latest addition to its research network: Carilion Clinic, a not-for-profit healthcare organization based in Roanoke, Virginia. By joinin...

Research with made-in-Canada molecule targets fungal infections worldwide

(Canadian Glycomics Network) People whose immune systems are compromised from illnesses such as cancer can also fall victim to infections caused by fungal pathogens, which have become a major. GlycoNe...

Immune system emerges as partner in opioid cravings fight

Review discusses complexity of immune-suppressive mechanisms in tumor milieu of cancers

Cancers control immune systems and evade immune detection using mediators consisting of immune checkpoint molecules and cellular systems associated with immune suppression.

‘Silenced’ immune cells can be activated to fight diseases

A research team at Garvan Institute of Medical Research in Australia has discovered that certain cells in the immune system...Read More... The post ‘Silenced’ immune cells can be activated to figh...

Innovative collaborative research network to be led by Wake Forest, with AFAR

(American Federation for Aging Research) The National Institute on Aging (NIA) at NIH has awarded funds, expected to total $2.5 million over three years, to the Wake Forest School of Medicine, with a ...

Immune System Checkpoint Failure Linked to Type 1 Diabetes in Mice

NewsAn immune reaction is usually a good thing--but sometimes the system goes into overdrive. Molecular checkpoints prevent the immune system from attacking healthy cells and organs.

PubMed Articles [3949 Associated PubMed Articles listed on BioPortfolio]

Crohn's and Colitis Foundation of America Partners Patient-Powered Research Network: Patient Perspectives on Facilitators and Barriers to Building an Impactful Patient-Powered Research Network.

To build a patient-powered research network (PPRN) that prioritizes the needs of its members who have inflammatory bowel diseases (IBD), we sought to better understand patients' preferences for what a...

Research consortium Neuroimmunology and pain in the research network musculoskeletal diseases.

The research consortium Neuroimmunology and Pain (Neuroimpa) explores the importance of the relationships between the immune system and the nervous system in musculoskeletal diseases for the generatio...

Dynamics of virus and immune response in multi-epitope network.

The host immune response can often efficiently suppress a virus infection, which may lead to selection for immune-resistant viral variants within the host. For example, during HIV infection, an array ...

Engaging Latina breast cancer survivors in research: building a social network research registry.

Disparities persist in breast cancer outcomes between Latina survivors and non-Hispanic Whites. Identifying methods to ensure that Latinas participate in and benefit from translational behavioral medi...

Immune checkpoint failures in inflammatory myopathies: An overview.

Dermatomyositis (DM), polymyositis (PM), inclusion bosy myositis (IBM), immune mediated necrotizing myopathy (IMNM) and overlap myositis (OM) are classified as inflammatory myopathies (IM) with involv...

Clinical Trials [4879 Associated Clinical Trials listed on BioPortfolio]

Participation in a Research Registry for Immune Disorders

Background: - People with primary immune deficiency diseases (PIDD) have weak immune systems. This makes it hard for their bodies to fight infection. The Immune Deficiency Foundation has ...

French Clinical Datbase of Melanoma Patients (RIC-Mel)

With a high incidence, low survival rates and limiter availability of effective treatment, melanoma is one of the research priorities for health authorities. Optimizing the development of ...

COPD Patient-Powered Research Network

The COPD Patient-Powered Research Network (COPD PPRN) is a patient research registry with the goal of enrolling 75,000 or more COPD patients and those at risk who are willing to share thei...

Assessing Community Cancer Care After Insurance ExpanSionS

This innovative and timely study will measure the impact of Affordable Care Act (ACA) Medicaid expansions on cancer screenings and preventive services. To assess this natural policy experi...

Blood and Marrow Transplant Clinical Research Network

The purpose of this network is to accelerate research in hematopoietic stem cell transplantation by comparing novel therapies to existing ones.

Companies [2247 Associated Companies listed on BioPortfolio]

Immune Network Research Limited

Profile:A Vancouver, BC - based company, Immune Network Research Ltd. identifies outstanding commercial opportunities for new drug treatments, and takes them closer to market through rapid completion ...

Microsulis Medical Limited

Founded in 1997, Microsulis Medical Limited is a UK-based medical device company that exploits specialist intellectual property in medical microwave design to create therapeutic d...

BC Proteomics Network

The BC Proteomics Network (BCPN) is a growing network of researchers and informatics professionals from universities, research institutions and industry throughout British Columbia.  Formed in ...

iBridge Network

The iBridge(SM) Network is an innovation catalyst with a vibrant, online community enabling universities, companies and entrepreneurs to connect, collaborate and license tomorrow's research, products ...

National Institute for Health Research, Clinical Research Network

The Clinical Research Network is part of the National Institute for Health Research - the research arm of the National Health Service in England. The Clinical Research Network pro...

More Information about "Immune Network Research Limited" on BioPortfolio

We have published hundreds of Immune Network Research Limited news stories on BioPortfolio along with dozens of Immune Network Research Limited Clinical Trials and PubMed Articles about Immune Network Research Limited for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Immune Network Research Limited Companies in our database. You can also find out about relevant Immune Network Research Limited Drugs and Medications on this site too.

Quick Search


Relevant Topics

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...

Mergers & Acquisitions
Commercial and market reports on mergers and acquisitions in the biotechnology, pharmaceutical, medical device and life-science industries. Mergers and acquisitions (abbreviated M&A;) is an aspect of corporate strategy, corporate finance and manageme...

Corporate Database Quicklinks

Searches Linking to this Company Record